Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H F Dullens

Showing results (61-70 of 70) with videos related to

Pageof 7
Sort By:
You have reached the last page of results.This site can display upto 70 results.
International Journal of Cancer|March 1, 1994
Effect of immunomodulators on specific tumor immunity induced by liposome-encapsulated tumor-associated antigensJ J Bergers, W Den Otter, H F Dullens, et al.
Cancer Immunology, Immunotherapy : CII|September 1, 1993
Critical factors for liposome-incorporated tumour-associated antigens to induce protective tumour immunity to SL2 lymphoma cells in miceJ J Bergers, W Den Otter, H F Dullens, et al.
Journal of Cranio-Maxillo-Facial Surgery : Official Publication of the European Association for Cranio-Maxillo-Facial Surgery|October 25, 2001
Tumour embolization of the Vx2 rabbit head and neck cancer model with Dextran hydrogel and Holmium-poly(L-lactic acid) microspheres: a radionuclide and histological pilot studyR J van Es, J F Nijsen, H F Dullens, et al.
Radiation Oncology Investigations|September 24, 1999
Prognostic relevance of MIB-1 immunoreactivity, S-phase fraction, 5-bromo-2'-deoxyuridine labeling indices, and mitotic figures in gliomasH Struikmans, D H Rutgers, G H Jansen, et al.
Cancer Immunology, Immunotherapy : CII|January 1, 1989
Initial immunochemical characterization of specific macrophage-arming factorR A De Weger, R J Vandebriel, H Slager, et al.
Cancer Immunology, Immunotherapy : CII|January 1, 1992
Reconstituted membranes of tumour cells (proteoliposomes) induce specific protection to murine lymphoma cellsJ J Bergers, W Den Otter, J W De Groot, et al.
Biotherapy (Dordrecht, Netherlands)|January 1, 1993
Histological analysis of IL-2 induced regression of murine solid SL2-tumorsR A Maas, H F Dullens, D Henk, et al.
Journal of Immunological Methods|June 24, 1983
An improved method of unit gravity sedimentation separation for murine peritoneal macrophage populationsR A De Weger, J M Verbakel, R Oskam, et al.
International Journal of Cancer|November 5, 1997
Local low-dose interleukin-2 induces systemic immunity when combined with radiotherapy of cancer. A pre-clinical studyL A Everse, I B Renes, I M Jürgenliemk-Schulz, et al.
In Vivo (Athens, Greece)|November 1, 1991
Effective immunotherapy with local low doses of interleukin-2W Den Otter, R A Maas, J W Koten, et al.
Pageof 7

Showing results (61-70 of 70) with videos related to

Sort By:
Pageof 7
You have reached the last page of results.This site can display upto 70 results.
International Journal of Cancer|March 1, 1994
Effect of immunomodulators on specific tumor immunity induced by liposome-encapsulated tumor-associated antigensJ J Bergers, W Den Otter, H F Dullens, et al.
Cancer Immunology, Immunotherapy : CII|September 1, 1993
Critical factors for liposome-incorporated tumour-associated antigens to induce protective tumour immunity to SL2 lymphoma cells in miceJ J Bergers, W Den Otter, H F Dullens, et al.
Journal of Cranio-Maxillo-Facial Surgery : Official Publication of the European Association for Cranio-Maxillo-Facial Surgery|October 25, 2001
Tumour embolization of the Vx2 rabbit head and neck cancer model with Dextran hydrogel and Holmium-poly(L-lactic acid) microspheres: a radionuclide and histological pilot studyR J van Es, J F Nijsen, H F Dullens, et al.
Radiation Oncology Investigations|September 24, 1999
Prognostic relevance of MIB-1 immunoreactivity, S-phase fraction, 5-bromo-2'-deoxyuridine labeling indices, and mitotic figures in gliomasH Struikmans, D H Rutgers, G H Jansen, et al.
Cancer Immunology, Immunotherapy : CII|January 1, 1989
Initial immunochemical characterization of specific macrophage-arming factorR A De Weger, R J Vandebriel, H Slager, et al.
Cancer Immunology, Immunotherapy : CII|January 1, 1992
Reconstituted membranes of tumour cells (proteoliposomes) induce specific protection to murine lymphoma cellsJ J Bergers, W Den Otter, J W De Groot, et al.
Biotherapy (Dordrecht, Netherlands)|January 1, 1993
Histological analysis of IL-2 induced regression of murine solid SL2-tumorsR A Maas, H F Dullens, D Henk, et al.
Journal of Immunological Methods|June 24, 1983
An improved method of unit gravity sedimentation separation for murine peritoneal macrophage populationsR A De Weger, J M Verbakel, R Oskam, et al.
International Journal of Cancer|November 5, 1997
Local low-dose interleukin-2 induces systemic immunity when combined with radiotherapy of cancer. A pre-clinical studyL A Everse, I B Renes, I M Jürgenliemk-Schulz, et al.
In Vivo (Athens, Greece)|November 1, 1991
Effective immunotherapy with local low doses of interleukin-2W Den Otter, R A Maas, J W Koten, et al.
Pageof 7